Product image of Lefloxawill (Levofloxacin Hemihydrate) supplied by GNH India

Lefloxawill

Active Ingredient:
Levofloxacin Hemihydrate
Origin:
EU

Lefloxawill (Levofloxacin Hemihydrate)

Levofloxacin Hemihydrate, the active ingredient in Lefloxawill, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It is prescribed for a range of bacterial infections affecting the urinary, respiratory, skin, and abdominal systems in adult patients.

GNH India supplies Lefloxawill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Goodwill Pharma Nyrt.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lefloxawill is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems.

  • Urinary tract infections: eradicates common uropathogens causing uncomplicated and complicated UTIs.
  • Respiratory tract infections: treats community‑acquired pneumonia and other lower respiratory infections.
  • Skin and soft tissue infections: effective against cellulitis and wound infections.
  • Prostatitis: resolves bacterial inflammation of the prostate gland.
  • Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic organisms.

How It Works

  • Levofloxacin Hemihydrate inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to these enzymes, it prevents DNA synthesis and transcription, leading to bacterial cell death. This bactericidal action is broad‑spectrum, covering many Gram‑negative and Gram‑positive organisms.

Side Effects

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Rash: mild skin erythema.
  • Photosensitivity: increased sun sensitivity.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles tendon injury.
  • QT prolongation: potential cardiac arrhythmia.
  • Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome.
  • Peripheral neuropathy: numbness or tingling.
  • Clostridioides difficile colitis: severe intestinal infection.

Precautions & Warnings

Before prescribing Lefloxawill, consider patient‑specific factors and safety measures.

  • Renal impairment: adjust dose or monitor renal function.
  • History of tendon disorders: avoid in patients with prior tendon injury.
  • Cardiac risk: caution in patients with known QT prolongation.
  • Concomitant CNS stimulants: monitor for increased CNS effects.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levofloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce absorption of levofloxacin.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • NSAIDs (e.g., ibuprofen): heightened risk of CNS stimulation and seizures.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: increased chance of tendon rupture.
  • Theophylline: possible elevation of plasma theophylline levels.
  • Cyclosporine: may raise cyclosporine concentrations.

Frequently Asked Questions

Lefloxawill, containing levofloxacin hemihydrate, is indicated for urinary tract infections, community‑acquired pneumonia and other respiratory infections, skin and soft‑tissue infections, prostatitis, and complicated intra‑abdominal infections caused by susceptible bacteria.

Levofloxacin hemihydrate blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibiting these targets prevents bacterial cells from multiplying, leading to a bactericidal effect against a broad range of Gram‑negative and Gram‑positive organisms.

The specific dose of Lefloxawill is determined by the prescribing clinician based on the type and severity of infection, patient age, renal function, and other clinical factors. Healthcare professionals should follow local prescribing guidelines and adjust as needed.

Levofloxacin is generally reserved for pregnancy or lactation only when the potential benefit justifies the potential risk to the fetus or infant. Clinicians should evaluate the risk‑benefit profile and consider alternative agents when possible.

To request Lefloxawill, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lefloxawill (levofloxacin) offers once‑daily dosing and a broad spectrum of activity similar to other fluoroquinolones such as ciprofloxacin. It has enhanced activity against Gram‑positive organisms and better lung penetration, making it a preferred option for respiratory infections, while sharing the class‑wide safety considerations.

Lefloxawill should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Lefloxawill is taken orally, usually as a tablet or oral solution, with or without food as directed by the prescriber. The exact administration instructions, including timing and whether to take with water, are provided by the healthcare professional.

Serious risks include tendon rupture (especially Achilles), QT interval prolongation leading to cardiac arrhythmias, severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome, peripheral neuropathy, and Clostridioides difficile‑associated colitis. Patients should be monitored for these events.

Lefloxawill is contraindicated in patients with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. Caution is advised for individuals with a history of tendon disorders, uncontrolled cardiac arrhythmias, or severe renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levofloxacin Hemihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT